SEC Form 4 · accession 0001179110-17-001472
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 3:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 31, 2017 | S | 5,000 | $18.00 | D | 178,222 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2015.
- F2This balance of shares beneficially owned reflects 646 shares acquired under the employee stock plan at a purchase price of $9.64 per share on January 31, 2017.